Next Article in Journal
Optimization of Taste-Masked (–)-Oleocanthal Effervescent Formulation with Potent Breast Cancer Progression and Recurrence Suppressive Activities
Next Article in Special Issue
A Combinatorial Cell and Drug Delivery Strategy for Huntington’s Disease Using Pharmacologically Active Microcarriers and RNAi Neuronally-Committed Mesenchymal Stromal Cells
Previous Article in Journal
Swelling of Zein Matrix Tablets Benchmarked against HPMC and Ethylcellulose: Challenging the Matrix Performance by the Addition of Co-Excipients
Previous Article in Special Issue
Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques
Article

Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets

1
School of Pharmacy and Biological Sciences, Royal College of Surgeons in Ireland, 2 Dublin, Ireland
2
School of Medicine, Royal College of Surgeons in Ireland, 2 Dublin, Ireland
*
Author to whom correspondence should be addressed.
Received: 23 August 2019 / Revised: 25 September 2019 / Accepted: 26 September 2019 / Published: 4 October 2019
(This article belongs to the Special Issue PLGA Based Drug Carrier and Pharmaceutical Applications)
Nanotechnology is being increasingly utilised in medicine as diagnostics and for drug delivery and targeting. The small size and high surface area of nanoparticles (NPs), desirable properties that allow them to cross biological barriers, also offer potential for interaction with other cells and blood constituents, presenting possible safety risks. While NPs investigated are predominantly based on the biodegradable, biocompatible, and FDA approved poly-lactide-co-glycolide (PLGA) polymers, pro-aggregatory and antiplatelet effects have been reported for certain NPs. The potential for toxicity of PLGA based NPs remains to be examined. The aims of this study were to determine the impact of size-selected PLGA-PEG (PLGA-polyethylene glycol) NPs on platelet activation and aggregation. PLGA-PEG NPs of three average sizes of 112, 348, and 576 nm were formulated and their effect at concentrations of 0.0–2.2 mg/mL on the activation and aggregation of washed human platelets (WP) was examined. The results of this study show, for the first time, NPs of all sizes associated with the surface of platelets, with >50% binding, leading to possible internalisation. The NP-platelet interaction, however, did not lead to platelet aggregation nor inhibited aggregation of platelets induced by thrombin. The outcome of this study is promising, suggesting that these NPs could be potential carriers for targeted drug delivery to platelets. View Full-Text
Keywords: PLGA-PEG; nanoparticles; platelet; activation; aggregation; binding; uptake PLGA-PEG; nanoparticles; platelet; activation; aggregation; binding; uptake
Show Figures

Graphical abstract

MDPI and ACS Style

Bakhaidar, R.; Green, J.; Alfahad, K.; Samanani, S.; Moollan, N.; O’Neill, S.; Ramtoola, Z. Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets. Pharmaceutics 2019, 11, 514. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics11100514

AMA Style

Bakhaidar R, Green J, Alfahad K, Samanani S, Moollan N, O’Neill S, Ramtoola Z. Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets. Pharmaceutics. 2019; 11(10):514. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics11100514

Chicago/Turabian Style

Bakhaidar, Rana, Joshua Green, Khaled Alfahad, Shazia Samanani, Nabeehah Moollan, Sarah O’Neill, and Zebunnissa Ramtoola. 2019. "Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets" Pharmaceutics 11, no. 10: 514. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics11100514

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop